What is the average price target for SPRINKLR INC-A (CXM) stock?
13 analysts have analysed CXM and the average price target is 8.67 USD. This implies a price increase of 53.45% is expected in the next year compared to the current price of 5.65.
NYSE:CXM • US85208T1079
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SPRINKLR INC-A (CXM).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-16 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2026-03-12 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2026-03-12 | DA Davidson | Maintains | Neutral -> Neutral |
| 2026-03-12 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-12-08 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-12-04 | DA Davidson | Maintains | Neutral -> Neutral |
| 2025-12-04 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-11-24 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-09-30 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-09-09 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-09-04 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-09-04 | Barclays | Maintains | Underweight -> Underweight |
| 2025-06-27 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-06-05 | DA Davidson | Maintains | Neutral -> Neutral |
| 2025-06-05 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-06-05 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-06-05 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2025-06-05 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-22 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2025-04-16 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-14 | DA Davidson | Maintains | Neutral -> Neutral |
| 2025-03-13 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-03-13 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2025-03-13 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-03-13 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 732.36M 18.47% | 796.394M 8.74% | 857.2M 7.64% | 878.8M 2.52% | 922.25M 4.94% | 994.49M 7.83% | 1.146B 15.23% | |
| EBITDA YoY % growth | 49.411M 226.21% | 45.449M -8.02% | 76.088M 67.41% | 170.38M 123.92% | 186.45M 9.43% | 236.95M 27.09% | 273.31M 15.35% | |
| EBIT YoY % growth | 33.945M 166.30% | 26.77M -21.14% | 57.024M 113.01% | 146.38M 156.70% | 163.99M 12.03% | 192.58M 17.43% | 225.43M 17.06% | |
| Operating Margin | 4.64% | 3.36% | 6.65% | 16.66% | 17.78% | 19.36% | 19.67% | |
| EPS YoY % growth | 0.39 | 0.35 -10.26% | 0.50 42.86% | 0.48 -4.07% | 0.51 6.13% | 0.42 -16.67% | 0.44 4.76% |
All data in USD
| Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | Q1 / 29 | Q2 / 29 | Q3 / 29 | Q4 / 29 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.10 -18.17% | 0.12 -4.00% | 0.13 8.85% | 0.13 1.69% | 0.12 20.76% | 0.13 6.99% | 0.14 3.92% | 0.14 9.25% | 0.15 27.77% | 0.16 21.03% | 0.16 19.05% | 0.16 11.89% |
| Revenue Q2Q % growth | 218.09M 6.13% | 217.85M 2.74% | 220.34M 0.58% | 222.5M 0.86% | 224.86M 3.10% | 226.76M 4.09% | 230.06M 4.41% | 235.38M 5.79% | 249.47M 10.94% | 254.68M 12.31% | 259.27M 12.70% | 266.78M 13.34% |
| EBITDA Q2Q % growth | 34.266M 78.13% | 44.403M 80.24% | 44.817M 71.01% | 45.201M 32.32% | 41.137M 20.05% | 44.778M 0.84% | 43.91M -2.02% | 44.804M -0.88% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 29.554M 103.01% | 37.76M 146.99% | 38.907M 222.05% | 40.193M 166.23% | 36.128M 22.24% | 39.42M 4.40% | 40.713M 4.64% | 43.572M 8.41% | 47.47M 31.39% | 51.17M 29.81% | 51.207M 25.78% | 53.164M 22.01% |
All data in USD
13 analysts have analysed CXM and the average price target is 8.67 USD. This implies a price increase of 53.45% is expected in the next year compared to the current price of 5.65.
SPRINKLR INC-A (CXM) will report earnings on 2026-06-02.
The consensus EPS estimate for the next earnings of SPRINKLR INC-A (CXM) is 0.1 USD and the consensus revenue estimate is 218.09M USD.
The consensus rating for SPRINKLR INC-A (CXM) is 69.2308 / 100 . This indicates that analysts generally have a neutral outlook on the stock.